Purchases and Sales Made in Q4 2024 in Unicycive Therapeutics, Inc. (UNCY)
This table provides information about the institutional ownership of Unicycive Therapeutics, Inc. (UNCY) during Q4 2024. The information is specifically focused on institutions that hold shares of Unicycive Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
Nantahala Capital Management, LLC
New Canaan, CT |
BUY
|
- |
7.57M+ 268.46% |
$2.65M - $6.13M
|
10.4M
$5.82M
|
|
Feb 13, 2025
Q4 2024
|
Vivo Capital, LLC
Palo Alto, CA |
BUY
|
- |
5.5M+ 123.04% |
$1.92M - $4.46M
|
9.97M
$5.58M
|
|
Feb 14, 2025
Q4 2024
|
Great Point Partners LLC
Greenwich, CT |
BUY
|
- |
2.42M+ 28.29% |
$847K - $1.96M
|
11M
$6.15M
|
|
Feb 14, 2025
Q4 2024
|
Octagon Capital Advisors LP
New York, NY |
BUY
|
- |
1.44M+ 16.84% |
$504K - $1.17M
|
10M
$5.6M
|
|
Feb 14, 2025
Q4 2024
|
Acuta Capital Partners, LLC
Belmont, CA |
BUY
|
- |
324K+ 16.36% |
$113K - $262K
|
2.3M
$1.29M
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
122K+ 30.34% |
$42.7K - $98.9K
|
524K
$294K
|
|
Feb 13, 2025
Q4 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
101K+ 142.23% |
$35.2K - $81.5K
|
171K
$96K
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
BUY
|
- |
81.3K+ 185.04% |
$28.5K - $65.9K
|
125K
$70.1K
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
34.2K+ 142.44% |
$12K - $27.7K
|
58.2K
$32.6K
|
|
Feb 14, 2025
Q4 2024
|
Hrt Financial LP
New York, NY |
BUY
|
- |
22.1KNew |
$7.75K - $17.9K
|
22.1K
$12.4K
|
|
Jan 23, 2025
Q4 2024
|
Hunter Associates Investment Management LLC
Pittsburgh, PA |
BUY
|
- |
15KNew |
$5.25K - $12.2K
|
15K
$8.4K
|
|
Feb 14, 2025
Q4 2024
|
Creative Planning
Overland Park, KS |
BUY
|
- |
12.4K+ 121.62% |
$4.36K - $10.1K
|
22.7K
$12.7K
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
5KNew |
$1.75K - $4.05K
|
5K
$2.8K
|
|
Jan 28, 2025
Q4 2024
|
Soa Wealth Advisors, Llc.
|
BUY
|
- |
1KNew |
$350 - $810
|
1K
$560
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
- |
587New |
$205 - $475
|
587
$329
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
74+ 22.29% |
$25.9 - $59.9
|
406
$227
|
|
Jan 29, 2025
Q4 2024
|
Bogart Wealth, LLC
|
BUY
|
- |
60New |
$21 - $48.6
|
60
$33.6
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
49New |
$17.2 - $39.7
|
49
$27.4
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-8- 3.86% |
$2.8 - $6.48
|
199
$111
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-11.9K- 52.21% |
$4.16K - $9.63K
|
10.9K
$6.1K
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-19.8K- 21.21% |
$6.94K - $16.1K
|
73.6K
$41.2K
|
|
Feb 14, 2025
Q4 2024
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-500K- 22.22% |
$175K - $405K
|
1.75M
$980K
|
|
Feb 14, 2025
Q4 2024
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-1.51M- 37.83% |
$530K - $1.23M
|
2.49M
$1.39M
|